Ponniah Thirumalaikolundusubramanian

Ponniah Thirumalaikolundusubramanian

Auto-generated profile, based on publicly available information

Ponniah Thirumalaikolundusubramanian


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
RMRamachandran Meenakshisundaram
Ramachandran Meenakshisundaram
SSSubramanian Senthilkumaran
Subramanian Senthilkumaran
PTPonniah Thirumalaikolundusubramanian
Ponniah Thirumalaikolundusubramanian
MJMelvin Joy
Melvin Joy
NJNarendra Nath Jena
Narendra Nath Jena
VCV.P. Chandrasekaran
V.P. Chandrasekaran
There has been a reduction in the reported cases of acute myocardial infarction (MI) across the globe during the outbreak of coronavirus disease 2019 (COVID-19) (severe acute respiratory distress syndrome coronavirus 2). An attempt was made to find out the number of acute MI cases treated during the COVID-19 lockdown period (April 2020) and highlight the possible reasons for the changes in the occurrence. A multicentric retrospective observational study was performed to collect the selected data from 12 private hospitals distributed in 4 cities—Madurai, Trichy (Thiruchirapalli), Erode, and Salem—of the Tamil Nadu state in southern India. There was a significant (P<.001) reduction in ST-segment elevation MI (STEMI), non-STEMI (NSTEMI), and total (STEMI and NSTEMI together) cases during the lockdown period (April 1 to 30, 2020) as compared with no-lockdown periods such as January and February 2020 and April 2019 and April 2018 in all cities, whereas the reduction was not significant for NSTEMI in Trichy when data for the lockdown period was compared with those for January and February 2020. Overall, there is a reduction in acute MI cases, which may be due to alterations in modifiable risk factors during the COVID-19 lockdown period. Hence, implementation of public education and polices on controlling modifiable risk factors is likely to pay dividends.

17 August 2021 in IETE Journal of Research
Verified
Journal Article
Closed access
DPDhivya P
Dhivya P
BABazilabanu A.
Bazilabanu A.
TPThirumalaikolundusubramanian Ponniah
Thirumalaikolundusubramanian Ponniah
The machine learning techniques can be used for clinical investigations in breast cancer diagnosis. The researchers investigated various machine learning algorithms, such as Support Vector Machine, Naïve Bayes, Logistic Regression (LR), Random Forest, Decision Tree and K Nearest Neighbor to diagnose the disease. Early detection of breast cancer cells from the features is essential. Feature selection is the process of reducing the input features to improve the performance of the model. This research aims to increase the accuracy, sensitivity, specificity and to reduce the False Positive Rate (FPR) and False Negative Rate (FNR) by feature selection. The proposed feature selection technique is comprised of two phases: feature grouping and feature selection. In the first phase, feature grouping uses the Pearson correlation techniques to identify the correlation among the features and group the features based on high-, medium- and low- level ranking. In the second phase, Triplet Feature Selection (TFS) method has been proposed to avoid collinearity among the features. In this, the features are selected based on the correlation differences in each subset when satisfying the race condition. Finally, select the features in the triplet group and apply LR classification technique to diagnose the disease. The proposed classifier achieved an accuracy (95.4%), FPR (1%), FNR (4%), sensitivity (97%) and specificity (96%) to detect the benign and malign ones. The effects of TFS feature selection with LR classifier were used and the performance of the proposed framework was compared with the existing feature selection methods and classifiers.

3 March 2023 in Toxins
Verified
Journal Article
Open access
PDF file
Subramanian SenthilkumaranSubramanian Senthilkumaran
Subramanian Senthilkumaran
ASAnika Salim
Anika Salim
José Rafael de AlmeidaJosé Rafael de Almeida
José Rafael de Almeida
JWJarred williams
Jarred williams
PVPradeep Vijayakumar
Pradeep Vijayakumar
Sakthivel VaiyapuriSakthivel Vaiyapuri
Sakthivel Vaiyapuri
Snakebite envenomation (SBE) is a life-threatening medical emergency with a high mortality rate. Common secondary complications following SBE, such as wound infections, are significant due to their impact on worsening local tissue damage and causing systemic infection. Antivenoms are not effective to treat wound infections following SBE. Moreover, in several rural clinical settings, broad-spectrum antibiotics are often used without clear guidelines or based on limited laboratory data, resulting in undesirable side effects and exacerbated treatment costs. Therefore, robust antibiotic strategies should be developed to tackle this critical issue. Currently, there is limited information available on the bacterial profiles of SBE-induced infections and antibiotic susceptibility. Hence, it is essential to improve the knowledge of bacterial profiles and their antibiotic sensitivity in SBE victims to develop better treatment strategies. This study aimed to address this issue by examining the bacterial profiles of SBE victims with a specific focus on Russell’s viper envenomation. The most frequently found bacteria in the bites of SBE victims were Staphylococcus aureus, Klebsiella sp., Escherichia coli, and Pseudomonas aeruginosa. Linezolid, clindamycin, colistin, meropenem, and amikacin were some of the most effective antibiotics for commonly grown bacteria in SBE victims. Similarly, ciprofloxacin, ampicillin, amoxiclave, cefixime, and tetracyclin were the least effective antibiotics for common bacteria found in the wound swabs of SBE victims. These data provide robust guidance for infection management following SBE and offer useful insights to aid in designing effective treatment protocols for SBE with serious wound infections in rural areas where laboratory facilities may not be readily available.

12 November 2021 in Toxins
Verified
Journal Article
Open access
PDF file
Subramanian SenthilkumaranSubramanian Senthilkumaran
Subramanian Senthilkumaran
KPKetan Patel
Ketan Patel
ASAnika Salim
Anika Salim
PVPradeep Vijayakumar
Pradeep Vijayakumar
HWHarry Fonseca Williams
Harry Fonseca Williams
Sakthivel VaiyapuriSakthivel Vaiyapuri
Sakthivel Vaiyapuri
Snakebite-induced acute kidney injury (AKI) is frequently observed in patients following bites from vipers such as Russell’s viper (Daboia russelii) in India. Currently, the levels of serum creatinine are mainly used as a marker to determine the necessity for renal replacement therapy (RRT) (haemodialysis) in severe cases of AKI. However, it takes up to 48 h to ascertain a distinct change in creatinine levels compared to its baseline level upon admission. The time lost between admission and the 48 h timepoint significantly affects the clinical management of snakebite victims. Moreover, early diagnosis of AKI and decision on the necessity for RRT in snakebite victims is critical in saving lives, reducing long-term complications, and minimising treatment costs arising from expensive haemodialysis. Neutrophil gelatinase–associated lipocalin (NGAL) has been recently studied as a robust early marker for AKI in non-snakebite patients. However, its suitability for clinical use in snakebite victims has not been rigorously established. Here, we demonstrate the clinical significance of plasma NGAL as a robust marker for RRT following AKI using a large cohort (309) of Russell’s viper victims without any pre-existing health conditions. NGAL levels upon admission are positively correlated with creatinine levels at 48 h in different stages of AKI. Overall, NGAL acts as a robust early marker to ascertain the need for RRT following Russell’s viper bites. The quantification of NGAL can be recommended as a routine test in hospitals that treat snakebites to decide on RRT at early time points instead of waiting for 48 h to confirm the increase in creatinine levels. The diagnostic use of NGAL in Russell’s viper victims with pre-existing comorbidities and for other vipers should be evaluated in future studies.

11 May 2024 in Toxins
Verified
Journal Article
Open access
PDF file
Subramanian SenthilkumaranSubramanian Senthilkumaran
Subramanian Senthilkumaran
SSSasikumar Sampath
Sasikumar Sampath
José Rafael de AlmeidaJosé Rafael de Almeida
José Rafael de Almeida
JWJarred williams
Jarred williams
HWHarry Fonseca Williams
Harry Fonseca Williams
Sakthivel VaiyapuriSakthivel Vaiyapuri
Sakthivel Vaiyapuri
Snakebite envenoming and its resulting complications are serious threats to the health of vulnerable people living in rural areas of developing countries. The knowledge of the heterogeneity of symptoms associated with snakebite envenoming and their management strategies is vital to treat such life-threatening complications to save lives. Russell’s viper envenomation induces a diverse range of clinical manifestations from commonly recognised haemotoxic and local effects to several rare conditions that are often not reported. The lack of awareness about these unusual manifestations can affect prompt diagnosis, appropriate therapeutic approaches, and positive outcomes for patients. Here, we report pulmonary thromboembolism that developed in three patients following Russell’s viper envenomation and demonstrate their common clinical features and diagnostic and therapeutic approaches used. All patients showed clinical signs of local (oedema) and systemic (blood coagulation disturbances) envenomation, which were treated using polyvalent antivenom. They exhibited elevated heart rates, breathlessness, and reduced oxygen saturation, which are non-specific but core parameters in the diagnosis of pulmonary embolism. The recognition of pulmonary embolism was also achieved by an electrocardiogram, which showed sinus tachycardia and computed tomography and echocardiogram scans further confirmed this condition. Anti-coagulant treatment using low-molecular-weight heparin offered clinical benefits in these patients. In summary, this report reinforces the broad spectrum of previously unreported consequences of Russell’s viper envenomation. The constant updating of healthcare professionals and the dissemination of major lessons learned in the clinical management of snakebite envenoming through scientific documentation and educational programs are necessary to mitigate the adverse impacts of venomous snakebites in vulnerable communities.

1 December 2013 in Journal of Neurosciences in Rural Practice
Verified
Journal Article
Open access
PDF file
Subramanian SenthilkumaranSubramanian Senthilkumaran
Subramanian Senthilkumaran
PSP Suresh
P Suresh
NBN Balamurugan
N Balamurugan
PTP Thirumalaikolundusubramanian
P Thirumalaikolundusubramanian
J Neurosci Rural Pract., official publication of Associacion Ayuda Enfermo Neuroquirurgico (Association for Helping Neurosurgical Sick People)